Cargando…
Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy
Purpose: This study aims to evaluate the predictive value of the pretreatment, metabolic, and diffusion parameters of a primary tumor assessed with PET/MR on patient clinical outcomes. Methods: Retrospective evaluation was performed using PET/MR image data sets acquired using the single tracer injec...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492555/ https://www.ncbi.nlm.nih.gov/pubmed/32983984 http://dx.doi.org/10.3389/fonc.2020.01484 |
_version_ | 1783582390840459264 |
---|---|
author | Kedves, András Tóth, Zoltán Emri, Miklós Fábián, Krisztián Sipos, Dávid Freihat, Omar Tollár, József Cselik, Zsolt Lakosi, Ferenc Bajzik, Gábor Repa, Imre Kovács, Árpád |
author_facet | Kedves, András Tóth, Zoltán Emri, Miklós Fábián, Krisztián Sipos, Dávid Freihat, Omar Tollár, József Cselik, Zsolt Lakosi, Ferenc Bajzik, Gábor Repa, Imre Kovács, Árpád |
author_sort | Kedves, András |
collection | PubMed |
description | Purpose: This study aims to evaluate the predictive value of the pretreatment, metabolic, and diffusion parameters of a primary tumor assessed with PET/MR on patient clinical outcomes. Methods: Retrospective evaluation was performed using PET/MR image data sets acquired using the single tracer injection dual imaging of 68 histologically proven head and neck cancer patients 4 weeks before receiving definitive chemoradiotherapy (CRT). PET/MR was performed before the CRT and 12 weeks after the CRT for response evaluation. Image data (PET and MRI diffusion-weighted imaging [DWI]) was used to specify the maximum standard uptake value, the peak lean body mass corrected, SUV(max), the metabolic tumor volume, the total lesion glycolysis (SUV(max), SUL(peak), MTV, and TLG), and the mean apparent diffusion coefficient (ADC(mean)) of the primary tumor. Based on the results of the therapeutic response evaluation, two patient subgroups were created: one with a viable tumor and another without. Metabolic and diffusion data, from the pretreatment PET/MR and the therapeutic response, were correlated using Spearman's correlation coefficient and Wilcoxon's test. Results: After completing the CRT, a viable residual tumor was detected in 36/68 (53%) cases, and 32/68 (47%) patients showed complete remission. However, no significant correlation was found between the pretreatment parameter, ADC(mean) (p = 0.88), and the therapeutic success. The PET parameters, SUV(max) and SUL(peak), MTV, and TLG (p = 0.032, p = 0.01, p < 0.0001, p = 0.0004) were statistically significantly different between the two patient subgroups. Conclusion: This study found that MRI-based (ADC(mean)) data from FDG PET/MR pretreatment could not be used to predict therapeutic response although the PET parameters SUV(max), SUL(peak), MTV, and TLG proved to be more useful; thus, their inclusion in risk stratification may also be of additional value. |
format | Online Article Text |
id | pubmed-7492555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74925552020-09-25 Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy Kedves, András Tóth, Zoltán Emri, Miklós Fábián, Krisztián Sipos, Dávid Freihat, Omar Tollár, József Cselik, Zsolt Lakosi, Ferenc Bajzik, Gábor Repa, Imre Kovács, Árpád Front Oncol Oncology Purpose: This study aims to evaluate the predictive value of the pretreatment, metabolic, and diffusion parameters of a primary tumor assessed with PET/MR on patient clinical outcomes. Methods: Retrospective evaluation was performed using PET/MR image data sets acquired using the single tracer injection dual imaging of 68 histologically proven head and neck cancer patients 4 weeks before receiving definitive chemoradiotherapy (CRT). PET/MR was performed before the CRT and 12 weeks after the CRT for response evaluation. Image data (PET and MRI diffusion-weighted imaging [DWI]) was used to specify the maximum standard uptake value, the peak lean body mass corrected, SUV(max), the metabolic tumor volume, the total lesion glycolysis (SUV(max), SUL(peak), MTV, and TLG), and the mean apparent diffusion coefficient (ADC(mean)) of the primary tumor. Based on the results of the therapeutic response evaluation, two patient subgroups were created: one with a viable tumor and another without. Metabolic and diffusion data, from the pretreatment PET/MR and the therapeutic response, were correlated using Spearman's correlation coefficient and Wilcoxon's test. Results: After completing the CRT, a viable residual tumor was detected in 36/68 (53%) cases, and 32/68 (47%) patients showed complete remission. However, no significant correlation was found between the pretreatment parameter, ADC(mean) (p = 0.88), and the therapeutic success. The PET parameters, SUV(max) and SUL(peak), MTV, and TLG (p = 0.032, p = 0.01, p < 0.0001, p = 0.0004) were statistically significantly different between the two patient subgroups. Conclusion: This study found that MRI-based (ADC(mean)) data from FDG PET/MR pretreatment could not be used to predict therapeutic response although the PET parameters SUV(max), SUL(peak), MTV, and TLG proved to be more useful; thus, their inclusion in risk stratification may also be of additional value. Frontiers Media S.A. 2020-09-02 /pmc/articles/PMC7492555/ /pubmed/32983984 http://dx.doi.org/10.3389/fonc.2020.01484 Text en Copyright © 2020 Kedves, Tóth, Emri, Fábián, Sipos, Freihat, Tollár, Cselik, Lakosi, Bajzik, Repa and Kovács. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Kedves, András Tóth, Zoltán Emri, Miklós Fábián, Krisztián Sipos, Dávid Freihat, Omar Tollár, József Cselik, Zsolt Lakosi, Ferenc Bajzik, Gábor Repa, Imre Kovács, Árpád Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy |
title | Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy |
title_full | Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy |
title_fullStr | Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy |
title_full_unstemmed | Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy |
title_short | Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy |
title_sort | predictive value of diffusion, glucose metabolism parameters of pet/mr in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492555/ https://www.ncbi.nlm.nih.gov/pubmed/32983984 http://dx.doi.org/10.3389/fonc.2020.01484 |
work_keys_str_mv | AT kedvesandras predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT tothzoltan predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT emrimiklos predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT fabiankrisztian predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT siposdavid predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT freihatomar predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT tollarjozsef predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT cselikzsolt predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT lakosiferenc predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT bajzikgabor predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT repaimre predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy AT kovacsarpad predictivevalueofdiffusionglucosemetabolismparametersofpetmrinpatientswithheadandnecksquamouscellcarcinomatreatedwithchemoradiotherapy |